NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	08/12/2015
Target sample size	600
Countries of recruitment	Asia except Japan,Japan,North America,South America,Europe,Oceania
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : Pembrolizumab Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : Paclitaxel Therapeutic category code : 424 Antineoplastic preparations extracted from plants Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : Docetaxel Therapeutic category code : 424 Antineoplastic preparations extracted from plants Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : Irinotecan Therapeutic category code : 424 Antineoplastic preparations extracted from plants Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	efficacy efficacy
Secondary Outcome	efficacy

Key inclusion & exclusion criteria

Age minimum	>= 18age old
Age maximum	Not applicable
Gender	Both
Include criteria
Exclude criteria